Biomed & Biotech Firms - Publicly Traded*

TearLab Corp.

Company Website

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

TearLab Corp.

Market Cap as of 6/12/2015

$80,106,408

Market Cap as of 7/03/2014

$168,262,859

Market Cap as of 07/02/2013

$324,482,727

Market Cap as of 06/26/2012

$75,725,555

Market Cap as of 01/04/2012

$28,172,690

Market Cap as of 06/20/2011

$24,500,450

Market Cap as of 01/06/2011

$36,471,510

Exchange and Ticker Symbol

Nasdaq: TEAR

Fields of Research

Develops and commercializes TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease

Major Products

TearLab Osmolarity System

Executives

Elias Vamvakas

  • Chairman
  • Chief Executive Officer

Similar Companies

Surgical and Medical Instrument Manufacturing339112
MEASURING AND CONTROLLING DEVICES, NOT ELSEWHERE CLASSIFIED3829
Surgical Appliance and Supplies Manufacturing339113
SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS3841